A national movement of thousands walking for a cure
Since its launch in 2013, Walk4BrainCancer has grown into a national movement drawing thousands of Australians from around the country each year. The Walk’s success has contributed to Cure Brain Cancer Foundation’s investment of over $30 million in brain cancer research. In the past year alone, the Foundation has committed $8 million to bring the GBM AGILE clinical trial to Australia, which aims to revolutionise the way treatments are tested and developed to treat glioblastoma. Our international expansion will help bridge the gap between Australian and international research, bringing Australia into the global landscape to accelerate treatments for all. In our search for a cure, there are no borders, no boundaries, and nothing will impede our mission to find a cure for this deadly disease.
Cure Brain Cancer Foundation is an Australian-based organisation, who is working globally to rapidly improve brain cancer survival. The Foundation’s mission is to unite the community and rapidly increase brain cancer survival, improving quality of life for people impacted by the disease, with a vision to ultimately find a cure for brain cancer. We’ll achieve this by empowering people living with brain cancer to have a strong influential voice, while raising awareness and funding for innovative research to accelerate quality treatments to patients.
Brain cancer kills more children than any other disease in Australia. It also kills more people under 40 in Australia than any other cancer. Yet very little is known about brain cancer, its causes or how to treat it.
Brain cancer survival rates are low and have hardly changed for 30 years, despite significant increases in survival for Australians diagnosed with other types of cancer, such as prostate and breast cancer. Treatment is challenging because it affects our most vital organ. Brain cancer costs more per person than any other cancer, yet only receives a small fraction of federal government cancer research funding.
Five-year survival for brain cancer has barely improved in more than 30 years and just one in five people diagnosed with brain cancer will survive for at least five years.